News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,537 Results
Type
Article (41507)
Company Profile (302)
Press Release (659728)
Section
Business (207732)
Career Advice (2042)
Deals (35762)
Drug Delivery (93)
Drug Development (82308)
Employer Resources (171)
FDA (16410)
Job Trends (15072)
News (350798)
Policy (33127)
Tag
Academia (2642)
Alliances (50720)
Alzheimer's disease (1304)
Approvals (16367)
Artificial intelligence (152)
Bankruptcy (355)
Best Places to Work (11739)
Biotechnology (212)
Breast cancer (191)
Cancer (1403)
Cardiovascular disease (118)
Career advice (1709)
Cell therapy (291)
Clinical research (65748)
Collaboration (505)
Compensation (262)
COVID-19 (2619)
C-suite (115)
Data (1407)
Diabetes (180)
Diagnostics (6297)
Earnings (85396)
Employer resources (149)
Events (111949)
Executive appointments (403)
FDA (17113)
Funding (444)
Gene therapy (202)
GLP-1 (625)
Government (4433)
Healthcare (19014)
Infectious disease (2715)
Inflammatory bowel disease (117)
Interviews (313)
IPO (16439)
Job creations (3750)
Job search strategy (1459)
Layoffs (431)
Legal (8019)
Lung cancer (201)
Manufacturing (213)
Medical device (13433)
Medtech (13438)
Mergers & acquisitions (19492)
Metabolic disorders (477)
Neuroscience (1636)
NextGen Class of 2024 (6615)
Non-profit (4608)
Northern California (1715)
Obesity (273)
Opinion (187)
Parkinson's disease (101)
Patents (120)
People (57882)
Phase I (20517)
Phase II (28938)
Phase III (21546)
Pipeline (521)
Postmarket research (2603)
Preclinical (8753)
Radiopharmaceuticals (239)
Rare diseases (273)
Real estate (6043)
Regulatory (22142)
Research institute (2419)
Resumes & cover letters (354)
Southern California (1476)
Startups (3683)
United States (15443)
Vaccines (580)
Weight loss (193)
Date
Today (126)
Last 7 days (583)
Last 30 days (2423)
Last 365 days (35931)
2024 (35774)
2023 (40728)
2022 (51874)
2021 (56457)
2020 (54788)
2019 (47409)
2018 (35753)
2017 (32898)
2016 (32349)
2015 (38362)
2014 (32062)
2013 (27112)
2012 (29191)
2011 (29878)
2010 (27952)
Location
Africa (742)
Arizona (196)
Asia (38347)
Australia (6323)
California (3863)
Canada (1465)
China (310)
Colorado (173)
Connecticut (183)
Europe (83681)
Florida (539)
Georgia (138)
Illinois (397)
Indiana (228)
Maryland (645)
Massachusetts (3025)
Michigan (176)
Minnesota (299)
New Jersey (1117)
New York (1096)
North Carolina (772)
Northern California (1715)
Ohio (146)
Pennsylvania (933)
South America (1129)
Southern California (1476)
Texas (557)
Utah (111)
Washington State (406)
701,537 Results for "milestone scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
November 15, 2024
·
10 min read
Policy
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has received regulatory approval from Brazil’s National Health Surveillance Agency (ANVISA) to market and sell its CompuFlo® Epidural System in Brazil.
June 18, 2024
·
4 min read
Business
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Milestone Scientific Inc. today provides a business update and announces financial results for the first quarter ended March 31, 2024.
May 16, 2024
·
9 min read
Business
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provides a business update and announces financial results for the year ending December 31, 2023.
April 1, 2024
·
10 min read
Press Releases
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
November 26, 2024
·
5 min read
Press Releases
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
December 3, 2024
·
2 min read
Business
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments.
May 13, 2024
·
1 min read
Press Releases
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
November 13, 2024
·
1 min read
Pharm Country
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
Milestone Scientific Inc. today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.
March 14, 2024
·
3 min read
Pharm Country
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock - December 08, 2023
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced that it has commenced an underwritten public offering of shares of its common stock.
December 8, 2023
·
4 min read
1 of 70,154
Next
